BioMed Realty News

The Platform at 585 Kendall addresses a documented need for a midsized professional theater that benefits the broader Cambridge arts community.

The state-of-the-art facility will consolidate Biogen’s operations and strengthen its nearly five-decade legacy of advancing breakthrough medicines.

The recognition is presented annually to individuals whose leadership and vision have left an enduring mark on the life sciences real estate industry.

Insmed has officially opened its new 17,000 square feet R&D facility, marking a significant expansion of its UK presence.

Fitwel, the leading global healthy building certification and data insights platform, recognizes BioMed Realty as a Fitwel Champion for its outstanding leadership in promoting health and wellness through the built environment.

BioMed Realty announced the acquisition of a majority interest in the 75 Broadway project in Cambridge, MA, through a joint venture partnership with the MIT Investment Management Company.

BioMed Realty, alongside Suffolk Construction, Takeda and Global Arts Live, celebrated the steel topping off of 585 Kendall, marking the placement of the final beam at the highest point of the building.

The 13,000-square-foot quantum incubator will be located at 5555 Central Ave., a 26,000-square-foot building at BioMed Realty’s Flatiron Park in Boulder.

BioMed Realty announced officer promotions of three team members: Johan Bostrom to Senior Vice President, Corporate Finance & Portfolio Insights, John Moshy to Senior Vice President, Development, and Matt Masterson to Vice President, Leasing.

Bob Nowak will lead the operations and facilities functions across the West Coast markets, which include San Diego, the San Francisco Bay Area, Seattle and Boulder.

BioMed Realty is a portfolio company within Blackstone’s Core+ Life Sciences Real Estate strategy, which achieved Real Estate Sector Leader status for Technology/Science as part of the 2024 GRESB Real Estate Assessment.

Mr. Lee oversees the Company’s Investment and Asset Management functions, including sourcing and underwriting new growth opportunities, as well as evaluating and capitalizing on opportunities to add value to its existing portfolio.